Snowball logo
logo
2U3

Alcon Inc.

€62.66€0.00  (0%)
Estimate
P/E
55.5
EPS
1.13
Beta
0.698
Growth
Revenue, YoY
11.65%
FCF, YoY
63.75%
Dividends
Dividend yield
0.52%
Annual payout
Fr0.30
Next ex. div date
May 5, 27
Payout
16.94%
Div.rating
About the company
Ticker
2U3
ISIN
CH0432492467
Country
Switzerland
Sector (GICS)
Healthcare
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Frequently asked questions

What sector does Alcon Inc. (2U3) operate in?

Alcon Inc. belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is Alcon Inc. (2U3) current stock price?

As of the latest data, Alcon Inc. stock price is €62.66, with a previous close of €62.66.

What is Alcon Inc. (2U3) current market capitalization?

Alcon Inc. market cap is approximately 30.29 billion.

What is Alcon Inc. (2U3) Earnings Per Share (EPS)?

The trailing EPS is €1.13.

What is Alcon Inc. (2U3) Price-to-Earnings (P/E) ratio?

Alcon Inc. current P/E ratio is 55.45.

Does Alcon Inc. (2U3) pay dividends?

Yes. Alcon Inc. pays annual dividends with an annualized yield of 0.52% and an estimated annual payout of €0.30 per share.

When is the next ex-dividend date for Alcon Inc. (2U3)?

The next ex-dividend date is scheduled for May 05, 2027.

When is Alcon Inc. (2U3) next earnings report?

Alcon Inc. is expected to release its next earnings report on September 30, 2026.

What is Alcon Inc. (2U3) beta (volatility) score?

Alcon Inc. has a beta of 0.698, indicating lower volatility than the overall market.